FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Emcure Pharma IPO and Stanley Lifestyles IPO.
Emcure Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Stanley Lifestyles IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Jefferies India Private Limited J.P. Morgan India Private Limited |
Axis Capital Limited ICICI Securities Limited Jm Financial Limited SBI Capital Markets Limited |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL |
The total issue size of Emcure Pharma IPO is whereas the issue size of the Stanley Lifestyles IPO is up to ₹537.02 Cr. The final issue price of Emcure Pharma IPO is and of Stanley Lifestyles IPO is ₹369.00 per share.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Face Value | ₹10 per share | ₹2 per share |
Issue Price (Lower) | ₹351.00 per share | |
Issue Price (Upper) | ₹369.00 per share | |
Issue Price (Final) | ₹369.00 per share | |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 40 shares | |
Fresh Issue Size | 54,20,054 shares | |
Fresh Issue Size (Amount) | up to ₹800.00 Cr | up to ₹200.00 Cr |
OFS Issue Size | 1,36,78,839 shares | 91,33,454 shares |
OFS Issue Size (Amount) | up to ₹337.02 Cr | |
Issue Size Total | 1,45,53,508 shares | |
Issue Size Total (Amount) | up to ₹537.02 Cr |
Emcure Pharma IPO opens on , while Stanley Lifestyles IPO opens on Jun 21, 2024. The closing date of Emcure Pharma IPO and Stanley Lifestyles IPO is , and Jun 25, 2024, respectively.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Anchor Bid Date | Jun 20, 2024 | |
Issue Open | Jun 21, 2024 | |
Issue Close | Jun 25, 2024 | |
Basis Of Allotment (Tentative) | Jun 26, 2024 | |
Initiation of Refunds (Tentative) | Jun 27, 2024 | |
Credit of Share (Tentative) | Jun 27, 2024 | |
Listing date (Tentative) | Jun 28, 2024 | |
Anchor Lockin End date 1 | Jul 26, 2024 | |
Anchor Lockin End date 2 | Sep 24, 2024 |
Emcure Pharma IPO P/E ratio is , as compared to Stanley Lifestyles IPO P/E ratio of 54.43.
Emcure Pharma IPO | Stanley Lifestyles IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
Stanley Lifestyles Limited Financial Information (Restated Consolidated)Stanley Lifestyles Limited's revenue increased by 42.94% and profit after tax (PAT) rose by 50.64% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 67.36% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 56.81% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 54.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹2103.94 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 7.92%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 8.63%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹6.78 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 8.34%% |
In the Emcure Pharma IPO retail investors (RII) are offered while in Stanley Lifestyles IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Emcure Pharma IPO and 29,10,702 shares in Stanley Lifestyles IPO.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
Anchor Investor Reserveration | 43,66,051 shares | |
Market Maker Reserveration | ||
QIB | 29,10,702 shares | |
NII | 21,83,026 shares | |
RII | 50,93,728 shares | |
Employee | 0 shares | |
Others | ||
Total | 1,01,87,456 shares |
Emcure Pharma IPO subscribed in total, whereas Stanley Lifestyles IPO subscribed 97.16x.
Emcure Pharma IPO | Stanley Lifestyles IPO | |
---|---|---|
QIB (times) | 215.62x | |
NII (times) | 121.42x | |
Big NII (times) | 136.75x | |
Small NII (times) | 90.76x | |
RII (times) | 19.08x | |
Employee (times) | ||
Other (times) | ||
Total (times) | 97.16x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|